Cryofocus Medtech (Shanghai) Co., Ltd.

HK$2.04As of Sun 8 Nov 2026, 12:00 UTC
HKEX:6922Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 4Y CAGR (42.91%)
Div yield —
ROE (55.97%)
Medical Devices
Beta (5Y) (0.74)
PE TTM —
TSR TTM (68.64%)
Mkt cap HK$498.0M
ROIC (21.42%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.14
5.20%
25.05%
Hold 7|4|6|7|4
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.03
0.03
0.03
0.04
0.76%
(1.33%)
14.73%
30.80%
Revenue¥M
58.91
62.42
66.05
65.01
9.55%
18.85%
19.80%
11.24%
Peers (US$63.52M)
Cap (US$)
PE
45.53M
—
63.92M
14.56x
Capital
TTM
5Y
10Y
Leveragex
0.857
0.988
0.656
EBIT/Intx
0.277
0.212
0.205
Own earn%
(121.16)
106.39
108.01
Sh yield%
10.67
46.98
48.33
Owners
Insiders/Inst%
14.11
62.14
Short interest%
1.79
SBC / revenue%
1.83
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
18–29
$1 testx
−0.1
Incr. ROIC%
14